FDA
-
-
-
-
-
-
-
Elanco Animal Health (ELAN) Reports Agreement to Acquire Aratana Therapeutics; Completes Oncology Development Agreement with VetDC, Creates Specialty Veterinary Business Focus
-
-
-
-
-
-
-
Aratana Therapeutics Reports First Quarter 2018 Financial Results
-
-
-
-
-
-
-
Aratana Therapeutics Announces Study Results for AT-016
-
-
-
-
-
-
-
Aratana Therapeutics (PETX) Announces Positive Results for AT-003 in Cats
-
-
-
-
-
-
-
Galliprant® (grapiprant tablets) Now Available for Canine Osteoarthritis
-
251,349 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All